Cargando…

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology

Antibiotics, along with oral corticosteroids, are standard treatments for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The ultimate aims of treatment are to minimize the impact of the current exacerbation, and by ensuring complete resolution, reduce the risk of relapse. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Robert, Anzueto, Antonio, Miravitlles, Marc, Arvis, Pierre, Faragó, Geneviève, Haverstock, Daniel, Trajanovic, Mila, Sethi, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133509/ https://www.ncbi.nlm.nih.gov/pubmed/21760724 http://dx.doi.org/10.2147/COPD.S21071

Ejemplares similares

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease
por: Sethi, S., et al.
Publicado: (2015)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

A comparison of methodologies for the real-time identification of hospitalized patients with acute exacerbations of COPD
por: Shah, Parth, et al.
Publicado: (2019)

Optimizing antibiotic selection in treating COPD exacerbations
por: Siddiqi, Attiya, et al.
Publicado: (2008)

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β(2)-agonist fixed-dose combination: RE(2)SPOND rationale and study design
por: Rennard, Stephen I, et al.
Publicado: (2016)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT(®) studies
por: Miravitlles, Marc, et al.
Publicado: (2009)

Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis
por: Sethi, Sanjay, et al.
Publicado: (2005)

Time To Revise COPD Treatment Algorithm
por: Matsunaga, Kazuto, et al.
Publicado: (2019)

Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?
por: Miravitlles, Marc, et al.
Publicado: (2017)

Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation
por: Lodewijckx, Cathy, et al.
Publicado: (2012)

Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life
por: Miravitlles, Marc, et al.
Publicado: (2010)

Long-term antibiotics in COPD: more benefit than harm?
por: Miravitlles, Marc
Publicado: (2013)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)

The need to further understand who gets hospitalized for a COPD exacerbation
por: Maselli, Diego J, et al.
Publicado: (2012)

Infectious Mechanisms Regulating Susceptibility to Acute Exacerbations of COPD
por: Provost, Karin, et al.
Publicado: (2013)

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
por: Miravitlles, Marc, et al.
Publicado: (2016)

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD
por: Papi, Alberto, et al.
Publicado: (2015)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD
por: Chu, Jen-hwa, et al.
Publicado: (2014)

Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Emergency department antibiotic use for exacerbations of COPD
por: Tichter, Aleksandr M, et al.
Publicado: (2018)

Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.
Publicado: (2012)

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
por: López-Campos, Jose Luis, et al.
Publicado: (2015)

4259 Application of Design Sprint Methodology to Prototype a Proactive Outreach Tool for COPD Patients
por: Cui, Michael, et al.
Publicado: (2020)

Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Sethi, Sanjay, et al.
Publicado: (2020)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Impact of statins and ACE inhibitors on mortality after COPD exacerbations
por: Mortensen, Eric M, et al.
Publicado: (2009)

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design
por: Richert, Laura, et al.
Publicado: (2014)

Tiotropium in chronic obstructive pulmonary disease – a review of clinical development
por: Anzueto, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_onhmc22qt8dp8kjjoa7b8412sf